Search research articles
Contact Us
Filters
Showing results (541-550 of 605) with videos related to
Page
of 61
Sort By:
Leukemia
|
January 23, 2013
JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms
J Wang, Z Xu, L Liu, et al.
Clinical Transplantation
|
February 29, 2000
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer
R P Gale, R E Park, R Dubois, et al.
The New England Journal of Medicine
|
September 10, 1981
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia
R G Strauss, J E Connett, R P Gale, et al.
Leukemia & Lymphoma
|
May 26, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma
R P Gale, R E Park, R W Dubois, et al.
British Medical Journal (Clinical Research Ed.)
|
February 28, 1981
Long survival in acute myelogenous leukaemia: an international collaborative study
J A Whittaker, P Reizenstein, S T Callender, et al.
Leukemia Research
|
August 24, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission
R P Gale, R E Park, R W Dubois, et al.
Bone Marrow Transplantation
|
November 26, 2013
Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantation
C O Freytes, D H Vesole, J LeRademacher, et al.
Leukemia Research
|
October 23, 1998
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission
R P Gale, R E Park, R W Dubois, et al.
Leukemia Research
|
September 4, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase
R P Gale, R E Park, R W Dubois, et al.
Blood
|
March 21, 1998
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group
R P Gale, R Hehlmann, M J Zhang, et al.
Page
of 61
Search research articles
Search
Showing results (541-550 of 605) with videos related to
Sort By:
Page
of 61
Leukemia
|
January 23, 2013
JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms
J Wang, Z Xu, L Liu, et al.
Clinical Transplantation
|
February 29, 2000
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer
R P Gale, R E Park, R Dubois, et al.
The New England Journal of Medicine
|
September 10, 1981
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia
R G Strauss, J E Connett, R P Gale, et al.
Leukemia & Lymphoma
|
May 26, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma
R P Gale, R E Park, R W Dubois, et al.
British Medical Journal (Clinical Research Ed.)
|
February 28, 1981
Long survival in acute myelogenous leukaemia: an international collaborative study
J A Whittaker, P Reizenstein, S T Callender, et al.
Leukemia Research
|
August 24, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission
R P Gale, R E Park, R W Dubois, et al.
Bone Marrow Transplantation
|
November 26, 2013
Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantation
C O Freytes, D H Vesole, J LeRademacher, et al.
Leukemia Research
|
October 23, 1998
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission
R P Gale, R E Park, R W Dubois, et al.
Leukemia Research
|
September 4, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase
R P Gale, R E Park, R W Dubois, et al.
Blood
|
March 21, 1998
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group
R P Gale, R Hehlmann, M J Zhang, et al.
Page
of 61